As Americans prepare for the busiest travel season of the year, a new survey fromUpgraded Points reveals that 62% of travelers prefer hotels to short-term rentals like Airbnb or Vrbo, citing better amenities, fewer fees, and greater price transparency as key factors in their decision. https://mma.prnewswire.com/media/2834512/image_1.jpg Surveying more than 2,000 U.S. travelers, the study explores […]

GearChain has launched a free Bulk GS1 Digital Link and Barcode Label Printer that streamlines how businesses create and print barcode labels at scale. The new tool enables users to generate UPC, Code 128, Code 39, QR, GS1 DataMatrix, and GS1 Digital Link labels in minutes by uploading a CSV file, previewing layouts, and seamlessly

(NASDAQ:CMND),(Frankfurt:CWY0), Vancouver, Canada, Dec. 01, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, recently announced three transformative milestones in its FDA-approved Phase I/IIa clinical trial for CMND-100–the Company's proprietary,

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial GlobeNewswire December 01, 2025 Vancouver, Canada, Dec. 01, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on December 1st — Stocks are little changed Monday morning as trading begins for December. The S&P 500 and Dow ended

Partnership brings health and community wellness education toRoku, AppleTV, and FireTV The ALIVE Podcast Network is proud to welcome CHC: Creating Healthier Communities as its newest content provider, bringing timely and transformative health-focused programming to audiences nationwide. CHC's thought-provoking health and community wellness content will begin rolling out across the ALIVE Podcast Network's CTV platforms

TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — AltCrest Energy (“AltCrest”), Development Engine Partners (“DevEngine”), and Spring Lane Capital (“Spring Lane”) are pleased to announce the launch of a strategic partnership to invest $100 million CAD into the rapidly growing distributed energy resource (“DER”) sector across Canada. The joint venture will focus on developing and owning

(NYSE MKT:AIM), OCALA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Closing Bell Series on Thursday, December 4, 2025 at 4:00 PM ET. As part of the

AltCrest Energy, DevEngine, and Spring Lane Capital Launch $100M Canadian Energy Investment Strategy GlobeNewswire December 01, 2025 TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — AltCrest Energy (“AltCrest”), Development Engine Partners (“DevEngine”), and Spring Lane Capital (“Spring Lane”) are pleased to announce the launch of a strategic partnership to invest $100 million CAD into the rapidly

AIM ImmunoTech to Participate in Live 'Fireside' Chat on Virtual Investor Closing Bell Series Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Thursday, December 4th at 4:00 PM ET GlobeNewswire December 01, 2025 OCALA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the